| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |